Skip to content
Screener

Disc Medicine IRON Operating Lease Liabilities

Operating Lease Liabilities at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.98B+29.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$6.82M-25.1%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$11.95M-61.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$135.85M-6.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.22M+189%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$90.07M+22.4%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.97B+45.5%
Enterprise value$2.92B+49.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The source filing: Disc Medicine’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 8:33 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205192
Line itemMarch 31,2026December 31,2025
Operating lease liabilities, current419611
Total current liabilities31,14236,641
Long-term debt, net29,36529,159
Operating lease liabilities, non-current1,2771,253
Total liabilities61,78467,053
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2026 and December 31, 2025

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Disc Medicine's operating lease liabilities?
Disc Medicine (IRON) reported operating lease liabilities of $1.28M in Q1 2026.
How has Disc Medicine's operating lease liabilities changed year-over-year?
Disc Medicine's operating lease liabilities decreased by 21.8% year-over-year, from $1.63M to $1.28M.
What is the long-term trend for Disc Medicine's operating lease liabilities?
Over 4 years (2021 to 2025), Disc Medicine's operating lease liabilities has grown at a -1.6% compound annual growth rate (CAGR), from $1.33M to $1.25M.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

Ask your AI about Disc Medicine's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude